AI-powered ServiceNow workflows for compliant, scalable life sciences operations.
Join USDM — ServiceNow’s exclusive Life Sciences partner — for an intimate lunch session on deploying AI-powered workflows across the full enterprise without sacrificing GxP integrity.
Why attend
GxP + ServiceNow. No compromises.
Most ServiceNow implementations in regulated environments trade platform agility for compliance posture — or vice versa. USDM’s approach does not. This session shows how to move faster with real-world examples from biopharma and med device.
Full value chain coverage
Practical use cases from R&D through manufacturing — all in a single compliant ServiceNow instance, without fragmentation.
GxP without the overhead
Data segregation strategies that satisfy FDA, EMA, and 21 CFR Part 11 requirements without creating technical debt that slows your roadmap.
Built to scale with ServiceNow
Keep your instance upgrade-friendly and ready to absorb every new ServiceNow release without rework or regression.
What we’re covering
- Accelerate time-to-value with less risk through pre-validated GxP workflows and life sciences-specific implementation.
- Lower total cost of ownership with purpose-built architecture and governance that reduce custom-build sprawl and technical debt.
- Operate with confidence in regulated environments through alignment to FDA and EU GxP expectations.
- Enable AI workflows that are audit-ready from day one, not retrofitted after the fact.
- Scale faster across the enterprise with a unified, compliant ServiceNow platform connecting R&D through manufacturing.
About USDM
USDM is the only ServiceNow SI built exclusively for life sciences. For 25 years, USDM has worked exclusively in pharma, biotech, and med device, solving the complex intersection of regulatory compliance, operational efficiency, and enterprise technology.
Whether you’re attending Knowledge26 or planning your next digital quality initiative, USDM helps you solve complex regulatory, operational, and technology challenges through ServiceNow.